COVID-19 mRNA Vaccine and Myocarditis.
COVID-19
COVID-19 vaccine
SARS-CoV-2
adverse events
inflammation of the heart
myocarditis
pericarditis
severe acute respiratory syndrome coronavirus 2
side effects
Journal
European journal of case reports in internal medicine
ISSN: 2284-2594
Titre abrégé: Eur J Case Rep Intern Med
Pays: Italy
ID NLM: 101648453
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
05
2021
accepted:
04
06
2021
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
17
7
2021
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up. Localized injection site reactions and systemic adverse effects can occur after administration of the various COVID-19 vaccines.Healthcare providers should maintain a high index of suspicion regarding myocarditis after mRNA COVID-19 vaccination in the appropriate clinical scenario.
Identifiants
pubmed: 34268277
doi: 10.12890/2021_002681
pii: 2681-1-23129-1-10-20210611
pmc: PMC8276934
doi:
Types de publication
Journal Article
Langues
eng
Pagination
002681Informations de copyright
© EFIM 2021.
Déclaration de conflit d'intérêts
Conflicts of Interests: The authors declare there are no competing interests.
Références
J Am Coll Cardiol. 2003 Aug 6;42(3):466-72
pubmed: 12906974
JAMA. 2003 Jun 25;289(24):3283-9
pubmed: 12824210
Trends Cardiovasc Med. 2021 Apr;31(3):163-169
pubmed: 33383171
Anatol J Cardiol. 2018 Apr;19(4):279-286
pubmed: 29537977
JAMA. 2021 Mar 16;325(11):1101-1102
pubmed: 33576785
N Engl J Med. 2021 Jun 3;384(22):2092-2101
pubmed: 33835769
Curr Opin Rheumatol. 2016 Jul;28(4):383-9
pubmed: 27166925